Alcohol withdrawal-induced change in lipoprotein(a) association with the growth hormone/insulin-like growth factor-I (IGF-I)/IGF-binding protein-1 (IGFBP-1) axis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 4, 1998, Pages 650-654

  Paassilta, Marita ^a   Kervinen, Kari ^a   Linnaluoto, Markku ^a   Antero Kesaniemi Y ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Alcohol; Insulin like growth factor binding protein 1; Insulin like growth factor I; Lipoprotein; Lipoprotein(a)

Indexed keywords

LIPOPROTEIN A; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY RISK; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK FACTOR; URINALYSIS;

EID: 0031967607     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.4.650     Document Type: Article

References (22)

1. Scanu AM, Fless GM. Lipoprotein(a): heterogeneity and biological relevance. J Clin Invest. 1990;85:1709-1715.
2. Schreiner PJ, Morrisett JD, Sharrett AR, Patsch W, Tyroler HA, Wu K, Heiss G. Lipoprotein(a) as a risk factor for preclinical atherosclerosis. Arterioscler Thromb. 1993;13:826-833.
3. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis E, Abolafia JM, Lippel K, Levy RI. Lipoprotein(a) levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial. JAMA. 1994;271:999-1003.
4. Utermann G. The mysteries of lipoprotein(a). Science. 1989;246:904-910.
5. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science. 1993;260:1655-1658.
6. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 1992;90:52-60.
7. Berglund L. Diet and drug therapy for lipoprotein(a). Curr Opin Lipidol. 1995;6:48-56.
8. Carlson LA, Hamsten A, Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med. 1989;226:271-276.
9. Seed M, O'Connor B, Perombelon N, O'Donnell M, Reaveley D, Knight BL. The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover. Atherosclerosis. 1993;101:61-68.
10. Kim CJ, Hak CJ, Dong HC, Yong KM. Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women. Arterioscler Thromb. 1994;14:275-281.
11. Haines C, Chung T, Chang A, Masarei J, Tomlinson B, Wong E. Effect of oral estradiol on Lp(a) and other lipoproteins in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study. Arch Intern Med. 1996;156:866-872.
12. Marth E, Gazzolato G, Bittolo Bon G, Avogaro P, Kostner GM. Serum concentrations of Lp(a) and other lipoprotein parameters in heavy alcohol consumers. Ann Nutr Metab. 1982;26:56-62.
13. Kervinen K, Savolainen MJ, Kesäniemi YA. A rapid rise in lipoprotein(a) levels after ethanol withdrawal in alcoholic men. Life Sci. 1991;48:2183-2188.
14. Paassilta M, Kervinen K, Rantala AO, Savolainen MJ, Lilja M, Reunanen A, Kesäniemi YA. Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study. BMJ. 1998. In press.
15. Huang CM, Elin RJ, Ruddel M, Schmitz J, Linnoila M. The effect of alcohol withdrawal on serum concentrations of Lp(a), apolipoproteins A-l and B, and lipids. Alcohol Clin Exp Res. 1992;16:895-898.
16. Oscarsson J, Lundstam U, Gustafsson B, Wilton P, Edén S, Wiklund O. Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men. Clin Endocrinol (Oxf). 1995;42:673-676.
17. Olivecrona H, Johansson AG, Lindh E, Ljunghall S, Berglund L, Angelin B. Hormonal regulation of serum lipoprotein(a) levels: contrasting effects of growth hormone and insulin-like growth factor-I. Arterioscler Thromb Vasc Biol. 1995;15:847-849.
18. Olivecrona H, Ericsson S, Berglund L, Angelin B. Increased concentrations of serum lipoprotein(a) in response to growth hormone treatment. BMJ. 1993;306:1726-1727.
19. Edén S, Wiklund O, Oscarsson J, Rosén T, Bengtsson B-Å. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL concentrations. Arterioscler Thromb. 1993;13:296-301.
20. Russell-Jones DL, Watts GF, Weissberger A, Naoumova R, Myers J, Thompson GR, Sönksen PH. The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol (Oxf). 1994;41:345-350.
21. Webster JM, Stewart M, Al-Maskari M, Osman I, Kendall-Taylor P, Mitcheson J, Laker MF. The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone-deficient adults. Atherosclerosis. 1997;133:115-121.
22. Marcovina SM, Morrisett JD. Structure and metabolism of lipoprotein(a). Curr Opin Lipidol. 1995;6:136-145.